EUVIMEDEUVIMED entdecken
Crossref

Alternative Splicing Factor Heterogeneous Nuclear Ribonucleoprotein U as a Promising Biomarker for Gastric Cancer Risk and Prognosis with Tumor-Promoting Properties

Ying-Ying Dong, Meng-Ya Wang, Jing-Jing Jing, Yi-Jun Wu, Hao Li, Yuan Yuan, Li-Ping Sun

The American Journal of Pathology · 2024

DOI: 10.1016/j.ajpath.2023.10.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Journal of Pathology, 2024. Verfasst von Ying-Ying Dong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Tumor Etiology and Screening Department of Cancer Institute and Key Laboratory of Cancer Etiology and Prevention in Liaoning Education Department, Th…. Hauptthemen laut MEDLINE: Stomach Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, Department of Science and Technology of Liaoning Province, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric cancer (GC) is a major global health concern with poor outcomes. Heterogeneous nuclear ribonucleoprotein U (HNRNPU) is a multifunctional protein that participates in pre-mRNA packaging, alternative splicing regulation, and chromatin remodeling. Its potential role in GC remains unclear. In this study, the expression characteristics of HNRNPU were analyzed by The Cancer Genome Atlas data, Gene Expression Omnibus data, and then further identified by real-time quantitative PCR and immunohistochemistry using tissue specimens. From superficial gastritis, atrophic gastritis, and hyperplasia to GC, the in situ expression of HNRNPU protein gradually increased, and the areas under the curve for diagnosis of GC and its precancerous lesions were 0.911 and 0.847, respectively. A nomogram integrating HNRNPU expression, lymph node metastasis, and other prognostic indicators exhibited an area under the curve of 0.785 for predicting survival risk. Knockdown of HNRNPU significantly inhibited GC cell proliferation, migration, and invasion and promoted apoptosis in vitro. In addition, RNA-sequencing analysis showed that HNRNPU could affect alternative splicing events in GC cells, with functional enrichment analysis revealing that HNRNPU may exert malignant biological function in GC progression through alternative splicing regulation. In summary, the increased expression of HNRNPU was significantly associated with the development of GC, with a good performance in diagnosing and predicting the prognostic risk of GC. Functionally, HNRNPU may play an oncogenic role in GC by regulating alternative splicing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsHumansAlternative SplicingBiomarkers, TumorCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticHeterogeneous-Nuclear Ribonucleoprotein UPrognosis

Substanzen

Biomarkers, TumorHeterogeneous-Nuclear Ribonucleoprotein UHNRNPU protein, human

Autor:innen und Institutionen

  • Tumor Etiology and Screening Department of Cancer Institute and Key Laboratory of Cancer Etiology and Prevention in Liaoning Education Department, The First Hospital of China Medical University, Shenyang, China; Key Lab…
  • Tumor Etiology and Screening Department of Cancer Institute and Key Laboratory of Cancer Etiology and Prevention in Liaoning Education Department, The First Hospital of China Medical University, Shenyang, China; Departm…
  • Department of Clinical Laboratory, The First Hospital of China Medical University, Shenyang, China.

Förderung

  • Ministry of Science and Technology of the People's Republic of China
  • Department of Science and Technology of Liaoning Province
  • National Key Research and Development Program of China
  • Key Research and Development Program of Liaoning Province

Zitieren

APA

Dong, Y. Y., Wang, M. Y., Jing, J. J., Wu, Y. J., Li, H., Yuan, Y., & Sun, L. P. (2024). Alternative Splicing Factor Heterogeneous Nuclear Ribonucleoprotein U as a Promising Biomarker for Gastric Cancer Risk and Prognosis with Tumor-Promoting Properties. The American Journal of Pathology. https://doi.org/10.1016/j.ajpath.2023.10.007

Vancouver

Dong YY, Wang MY, Jing JJ, Wu YJ, Li H, Yuan Y, et al. Alternative Splicing Factor Heterogeneous Nuclear Ribonucleoprotein U as a Promising Biomarker for Gastric Cancer Risk and Prognosis with Tumor-Promoting Properties. The American Journal of Pathology. 2024. doi:10.1016/j.ajpath.2023.10.007

BibTeX
@article{Dong2024,
  author = {Dong, Ying-Ying and Wang, Meng-Ya and Jing, Jing-Jing and Wu, Yi-Jun and Li, Hao and Yuan, Yuan and Sun, Li-Ping},
  title = {Alternative Splicing Factor Heterogeneous Nuclear Ribonucleoprotein U as a Promising Biomarker for Gastric Cancer Risk and Prognosis with Tumor-Promoting Properties},
  journal = {The American Journal of Pathology},
  year = {2024},
  doi = {10.1016/j.ajpath.2023.10.007}
}
Kostenlos starten →